MDXXF
Price
$0.21
Change
+$0.01 (+5.00%)
Updated
Nov 14 closing price
NICXF
Price
$0.24
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Ad is loading...

MDXXF vs NICXF

Header iconMDXXF vs NICXF Comparison
Open Charts MDXXF vs NICXFBanner chart's image
PharmAla Biotech Holdings
Price$0.21
Change+$0.01 (+5.00%)
Volume$24.15K
CapitalizationN/A
Nicox S.A
Price$0.24
Change-$0.00 (-0.00%)
Volume$250
CapitalizationN/A
MDXXF vs NICXF Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDXXF vs. NICXF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXXF is a Hold and NICXF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (MDXXF: $0.21 vs. NICXF: $0.24)
Brand notoriety: MDXXF and NICXF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXXF: 59% vs. NICXF: 222%
Market capitalization -- MDXXF: $20.57M vs. NICXF: $16.21M
MDXXF [@Biotechnology] is valued at $20.57M. NICXF’s [@Biotechnology] market capitalization is $16.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXXF’s FA Score shows that 0 FA rating(s) are green whileNICXF’s FA Score has 0 green FA rating(s).

  • MDXXF’s FA Score: 0 green, 5 red.
  • NICXF’s FA Score: 0 green, 5 red.
According to our system of comparison, MDXXF is a better buy in the long-term than NICXF.

Price Growth

MDXXF (@Biotechnology) experienced а +35.15% price change this week, while NICXF (@Biotechnology) price change was -45.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
MDXXF($20.6M) has a higher market cap than NICXF($16.2M). MDXXF YTD gains are higher at: 550.949 vs. NICXF (-45.455).
MDXXFNICXFMDXXF / NICXF
Capitalization20.6M16.2M127%
EBITDAN/AN/A-
Gain YTD550.949-45.455-1,212%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
NICXF: Fundamental Ratings
NICXF
OUTLOOK RATING
1..100
95
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

MDXXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXXF has been loosely correlated with NICXF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXXF jumps, then NICXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXXF
1D Price
Change %
MDXXF100%
+0.59%
NICXF - MDXXF
45%
Loosely correlated
N/A
IUGNF - MDXXF
23%
Poorly correlated
+4.92%
ZIVO - MDXXF
22%
Poorly correlated
+0.14%
NGNE - MDXXF
20%
Poorly correlated
-1.16%
TRML - MDXXF
13%
Poorly correlated
+2.36%
More

NICXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NICXF has been loosely correlated with MDXXF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NICXF jumps, then MDXXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NICXF
1D Price
Change %
NICXF100%
N/A
MDXXF - NICXF
45%
Loosely correlated
+0.59%
DNTH - NICXF
25%
Poorly correlated
-3.26%
TGTX - NICXF
24%
Poorly correlated
-11.62%
CYTK - NICXF
22%
Poorly correlated
-2.25%
CLVLF - NICXF
22%
Poorly correlated
-7.75%
More